Kevin Hendrawan
Herston, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2024
Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Journal: Cytotherapy
Published: February 20, 2023
Sustained immunotolerance in multiple sclerosis after stem cell transplant.
Journal: Annals of clinical and translational neurology
Published: November 10, 2021
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Journal: Frontiers in immunology
Published: October 20, 2021
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
Journal: Frontiers in immunology
Published: September 25, 2021
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.
Journal: Bone marrow transplantation
Published: May 29, 2019
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 13, 2018
The Regulation of Uterine Proinflammatory Gene Expression during Pregnancy in the Live-Bearing Lizard, Pseudemoia entrecasteauxii.
Journal: Journal of experimental zoology. Part B, Molecular and developmental evolution
Published: August 20, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026